Largo Reports Third Quarter 2023 Financial Results; Announces First Commercial Shipment of Ilmenite as By-Product of its Vanadium Operations in Brazil and Validation of its 6 MWh Vanadium Redox Flow B

Go back to Largo Reports Third Quarter 2023 Financial Results; Announces First Commercial Shipment of Ilmenite as By-Product of its Vanadium Operations in Brazil and Validation of its 6 MWh Vanadium Redox Flow B
BioLargo, Inc. (NASDAQ: LGO) Delayed: 0.71 -0.02 (2.74%)
Previous Close $0.73    52 Week High $0.60 
Open $0.73    52 Week Low $0.25 
Day High $0.74    P/E N/A 
Day Low $0.71    EPS $0.00 
Volume 238,981       

BioLargo, Inc. (NASDAQ: LGO) Delayed: 0.71 -0.02 (2.74%)
Previous Close $0.73    52 Week High $0.60 
Open $0.73    52 Week Low $0.25 
Day High $0.74    P/E N/A 
Day Low $0.71    EPS $0.00 
Volume 238,981